These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 3875286

  • 1. C1q nephropathy: a distinct pathologic entity usually causing nephrotic syndrome.
    Jennette JC, Hipp CG.
    Am J Kidney Dis; 1985 Aug; 6(2):103-10. PubMed ID: 3875286
    [Abstract] [Full Text] [Related]

  • 2. Immunohistopathologic evaluation of C1q in 800 renal biopsy specimens.
    Jennette JC, Hipp CG.
    Am J Clin Pathol; 1985 Apr; 83(4):415-20. PubMed ID: 3885712
    [Abstract] [Full Text] [Related]

  • 3. Nonsystemic mesangiopathic glomerulonephritis with "full house" immunofluorescence. Pathological and clinical observation in five patients.
    Jones E, Magil A.
    Am J Clin Pathol; 1982 Jul; 78(1):29-34. PubMed ID: 7048894
    [Abstract] [Full Text] [Related]

  • 4. Lupus nephritis: correlation between light, electron microscopic and immunofluorescent findings and renal function.
    Sinniah R, Feng PH.
    Clin Nephrol; 1976 Aug; 6(2):340-51. PubMed ID: 782752
    [Abstract] [Full Text] [Related]

  • 5. Spontaneous improvement in a case of C1q nephropathy.
    Nishida M, Kawakatsu H, Komatsu H, Ishiwari K, Tamai M, Sawada T.
    Am J Kidney Dis; 2000 May; 35(5):E22. PubMed ID: 10793051
    [Abstract] [Full Text] [Related]

  • 6. C1q nephropathy: do C1q deposits have any prognostic significance in the nephrotic syndrome?
    Davenport A, Maciver AG, Mackenzie JC.
    Nephrol Dial Transplant; 1992 May; 7(5):391-6. PubMed ID: 1321373
    [Abstract] [Full Text] [Related]

  • 7. C1q nephropathy: a variant of focal segmental glomerulosclerosis.
    Markowitz GS, Schwimmer JA, Stokes MB, Nasr S, Seigle RL, Valeri AM, D'Agati VD.
    Kidney Int; 2003 Oct; 64(4):1232-40. PubMed ID: 12969141
    [Abstract] [Full Text] [Related]

  • 8. Distinguishing C1q nephropathy from lupus nephritis.
    Sharman A, Furness P, Feehally J.
    Nephrol Dial Transplant; 2004 Jun; 19(6):1420-6. PubMed ID: 15004260
    [Abstract] [Full Text] [Related]

  • 9. Murine lupus nephritis: effects of cyclophosphamide on circulating and tissue bound immunoreactants.
    Cavallo T, Graves K, Granholm NA.
    Clin Exp Immunol; 1984 Jan; 55(1):67-73. PubMed ID: 6607142
    [Abstract] [Full Text] [Related]

  • 10. Clinical and immunopathologic study of mesangial IgM nephropathy: report of 41 cases.
    Hsu HC, Chen WY, Lin GJ, Chen L, Kao SL, Huang CC, Lin CY.
    Histopathology; 1984 May; 8(3):435-46. PubMed ID: 6376323
    [Abstract] [Full Text] [Related]

  • 11. C1Q nephropathy in children.
    Kersnik Levart T, Kenda RB, Avgustin Cavić M, Ferluga D, Hvala A, Vizjak A.
    Pediatr Nephrol; 2005 Dec; 20(12):1756-61. PubMed ID: 16247648
    [Abstract] [Full Text] [Related]

  • 12. Predominant but silent C1q deposits in mesangium on transplanted kidneys - long-term observational study.
    Kanai T, Akioka Y, Miura K, Hisano M, Koike J, Yamaguchi Y, Hattori M.
    BMC Nephrol; 2018 Apr 06; 19(1):82. PubMed ID: 29625558
    [Abstract] [Full Text] [Related]

  • 13. C1q nephropathy in two young sisters.
    Kari JA, Jalalah SM.
    Pediatr Nephrol; 2008 Mar 06; 23(3):487-90. PubMed ID: 17952693
    [Abstract] [Full Text] [Related]

  • 14. Pan-nephritis (glomerulonephritis, arteriolitis, and tubulointerstitial nephritis) associated with predominant mesangial C1q deposition and hypocomplementemia: a variant type of C1q nephropathy?
    Imai H, Yasuda T, Satoh K, Miura AB, Sugawara T, Nakamoto Y.
    Am J Kidney Dis; 1996 Apr 06; 27(4):583-7. PubMed ID: 8678071
    [Abstract] [Full Text] [Related]

  • 15. Pathology, clinical presentations, and outcomes of C1q nephropathy.
    Vizjak A, Ferluga D, Rozic M, Hvala A, Lindic J, Levart TK, Jurcić V, Jennette JC.
    J Am Soc Nephrol; 2008 Nov 06; 19(11):2237-44. PubMed ID: 18650484
    [Abstract] [Full Text] [Related]

  • 16. Current status and issues of C1q nephropathy.
    Mii A, Shimizu A, Masuda Y, Fujita E, Aki K, Ishizaki M, Sato S, Griesemer A, Fukuda Y.
    Clin Exp Nephrol; 2009 Aug 06; 13(4):263-274. PubMed ID: 19373520
    [Abstract] [Full Text] [Related]

  • 17. Immunopathology of early and clinically silent lupus nephropathy.
    Cavallo T, Cameron WR, Lapenas D.
    Am J Pathol; 1977 Apr 06; 87(1):1-18. PubMed ID: 322502
    [Abstract] [Full Text] [Related]

  • 18. C1q nephropathy in India: a single-center study.
    Kanodia KV, Vanikar AV, Patel RD, Suthar KS, Patel HV, Gumber MA, Shah PR, Trivedi HL.
    Saudi J Kidney Dis Transpl; 2015 Mar 06; 26(2):398-403. PubMed ID: 25758901
    [Abstract] [Full Text] [Related]

  • 19. C1q nephropathy presenting as rapidly progressive crescentic glomerulonephritis.
    Srivastava T, Chadha V, Taboada EM, Alon US.
    Pediatr Nephrol; 2000 Sep 06; 14(10-11):976-9. PubMed ID: 10975310
    [Abstract] [Full Text] [Related]

  • 20. C1q nephropathy: a pediatric clinicopathologic study.
    Iskandar SS, Browning MC, Lorentz WB.
    Am J Kidney Dis; 1991 Oct 06; 18(4):459-65. PubMed ID: 1928065
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.